Clinical Trial Update: STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial evaluating STA-4783 in combination with paclitaxel and carboplatin in chemotherapy-naïve patients with Stage IIIB/IV non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• STA-4783 (STA-4783)
• Taxol (paclitaxel)

Snippet

Sponsor: Synta Pharmaceuticals Corp. | Conditions: Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED